CivicaScript will offer dimethyl fumarate 240 mg capsules for sale to pharmacies for $47 per bottle of 60 capsules – typically a month's supply. CivicaScript recommends that pharmacies charge patients ...

BOUCHERVILLE, Quebec, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Sandoz Canada announced today the launch of Pr Sandoz ® Dimethyl Fumarate Delayed-Release Capsules, a generic equivalent to Biogen Canada’s Pr ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)-- Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr.Reddy’s”) today ...

MUMBAI, India, Sept. 28, 2020 /PRNewswire/ -- Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as "Cipla") today announced that it has received final approval for its Abbreviated ...

Mumbai (Maharashtra) [India] October 7 (ANI/PRNewswire): Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for ...

Shilpa Medicare shares spiked 8.75 percent intraday Friday after receiving tentative approval from the US health regulator for Dimethyl Fumarate delayed release capsules. Dimethyl Fumarate delayed ...

https://www.thehindubusinessline.com/companies/dr-reddys-launches-imethyl-fumarate-delayed-release-capsules-in-us/article32702730.ece Copy Dr Reddy’s Laboratories ...

The company's abbreviated new drug application (ANDA) for Dimethyl Fumarate delayed release capsules in the strengths of 120 mg and 240 mg has been granted tentative approval by the United States Food ...

BOSTON--(BUSINESS WIRE)--Cycle Pharmaceuticals Limited (Cycle) is pleased to announce that Cycle Vita is now available with BAFIERTAM, expanding its patient support services in MS, following the ...

HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr.Reddy’s”) today ...

Disclaimer: The following press release comes to you under an arrangement with PRNewswire. takes no editorial responsibility for the same.) MUMBAI, India, Oct. 7, 2020 /PRNewswire/ -- Glenmark ...

(Eds: Disclaimer: The following press release comes to you under an arrangement with PR Newswire. PTI takes no editorial responsibility for the same.) MUMBAI, Oct. 9, 2019 /PRNewswire/ -- Glenmark ...